Evidence map›Paper›PMID 27466253›Full record

ArticleMolecular & cellular proteomics : MCP2016

Fasciola hepatica Surface Tegument: Glycoproteins at the Interface of Parasite and Host.

Alessandra Ravidà, Krystyna Cwiklinski, Allison M Aldridge, Paul Clarke, Roisin Thompson, Jared Q Gerlach, Michelle Kilcoyne, Cornelis H Hokke, John P Dalton, Sandra M O'Neill

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Identification ofFrontiers in parasitology · 2026
    Article
  5. Deciphering theBiomolecules · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. An Update on the Pathogenesis of Fascioliasis: What Do We Know?Research and reports in tropical medicine · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Silencing TUBB3 Expression Destroys the Tegument and Flame Cells ofAnimals : an open access journal from MDPI · 2022
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Alessandra RavidàFrom the ‡Fundamental and Translational Immunology, School of Biotechnology, Faculty of Science and Health, Dublin City University, Glasnevin, Dublin 9, Ireland.
Krystyna Cwiklinski§School of Biological Sciences, Medical Biology Centre (MBC), Queen's University Belfast, Belfast, Northern Ireland, UK.
Allison M AldridgeFrom the ‡Fundamental and Translational Immunology, School of Biotechnology, Faculty of Science and Health, Dublin City University, Glasnevin, Dublin 9, Ireland.
Paul Clarke¶Glycoselect, Dublin City University, Glasnevin, Dublin 9.
Roisin Thompson¶Glycoselect, Dublin City University, Glasnevin, Dublin 9.
Jared Q Gerlach‖Glycoscience Group, National Centre for Biomedical Engineering Science, National University of Ireland Galway, Ireland; **Regenerative Medicine Institute, NUI Galway, Ireland.
Michelle Kilcoyne‖Glycoscience Group, National Centre for Biomedical Engineering Science, National University of Ireland Galway, Ireland; ‡‡Carbohydrate Signalling Group, Microbiology, NUI Galway, Ireland.
Cornelis H Hokke§§Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.
John P Dalton§School of Biological Sciences, Medical Biology Centre (MBC), Queen's University Belfast, Belfast, Northern Ireland, UK.
Sandra M O'NeillFrom the ‡Fundamental and Translational Immunology, School of Biotechnology, Faculty of Science and Health, Dublin City University, Glasnevin, Dublin 9, Ireland; Sandra.ONeill@dcu.ie.
Dublin City University · IEOllscoil na Gaillimhe – University of Galway · IEQueen's University Belfast · GBLeiden University Medical Center · NL

Funding

Wellcome TrustWellcome Trust WT094907MA
6 · The paper itself

Abstract

Fasciola hepatica, commonly known as liver fluke, is a trematode that causes Fasciolosis in ruminants and humans. The outer tegumental coat of F. hepatica (FhTeg) is a complex metabolically active biological matrix that is continually exposed to the host immune system and therefore makes a good vaccine target. F. hepatica tegumental coat is highly glycosylated and helminth-derived immunogenic oligosaccharide motifs and glycoproteins are currently being investigated as novel vaccine candidates. This report presents the first systematic characterization of FhTeg glycosylation using lectin microarrays to characterize carbohydrates motifs present, and lectin histochemistry to localize these on the F. hepatica tegument. We discovered that FhTeg glycoproteins are predominantly oligomannose oligosaccharides that are expressed on the spines, suckers and tegumental coat of F. hepatica and lectin blot analysis confirmed the abundance of N- glycosylated proteins. Although some oligosaccharides are widely distributed on the fluke surface other subsets are restricted to distinct anatomical regions. We selectively enriched for FhTeg mannosylated glycoprotein subsets using lectin affinity chromatography and identified 369 proteins by mass spectrometric analysis. Among these proteins are a number of potential vaccine candidates with known immune modulatory properties including proteases, protease inhibitors, paramyosin, Venom Allergen-like II, Enolase and two proteins, nardilysin and TRIL, that have not been previously associated with F. hepatica Furthermore, we provide a comprehensive insight regarding the putative glycosylation of FhTeg components that could highlight the importance of further studies examining glycoconjugates in host-parasite interactions in the context of F. hepatica infection and the development of an effective vaccine.

Indexed as

AnimalsFasciola hepaticaGlycoproteinsGlycosylationHelminth ProteinsHost-Parasite InteractionsLectinsMass SpectrometryProtein Array AnalysisProteomicsGlycoproteinsHelminth ProteinsLectins

Identifiers

PMID27466253
PMCPMC5054340
OpenAlexW2500491861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.